Celecoxib Capsules 1.2g – Grade COX?2 Inhibitor

Celecoxib Capsules 1.2g – Grade COX?2 Inhibitor

$1.00

Celecoxib is a selective COX?2 inhibitor (NSAID) commonly used in preclinical research to study inflammation, pain, cancer prevention, and cardiovascular risk. Each capsule contains 200?mg celecoxib. ?? For laboratory research use only.?Please consult the staff for other purposes?

EMI starting from $0.00/month - View Plans
Compare

Description

Product Specifications

AttributeDetails
Product NameCelecoxib Capsules
Generic NameCelecoxib
CAS Number169590?42?5
Molecular FormulaC??H??F?N?O?S
Molecular Weight~381.37?g/mol
Dosage FormOral capsule
Strength200?mg per capsule
Pack Size(e.g., 30 capsules)
Manufacturing ApprovalN/A (research grade)
ManufacturerSichuan Xinston Pharmaceutical
StorageStore at 15–25?°C, protect from moisture and light
Intended UseLaboratory research use only

Mechanism of Action

Celecoxib selectively inhibits cyclooxygenase?2 (COX?2), reducing prostaglandin synthesis involved in inflammation, pain, and fever—while sparing COX?1, reducing gastrointestinal side effects in research models.
zh.wikipedia.orgaccessdata.fda.gov+2de.wikipedia.org+2zh.wikipedia.org+2dailymed.nlm.nih.govncbi.nlm.nih.gov+1medcentral.com+1


Research Applications & Pharmacology

  • Inflammation & pain models: Used in osteoarthritis, rheumatoid arthritis, nociceptive pain, and dysmenorrhea studies.

  • Cancer/prevention models: Investigated for chemoprevention in familial adenomatous polyposis and COX?2?dependent tumor biology (e.g., colorectal, neuroblastoma).

  • Cardiovascular risk profiling: Employed in studies assessing thrombotic risk and COX?2 inhibitor safety.

  • Pharmacokinetics: Well absorbed, peak plasma 2–4 hrs, half-life ~6–12 hrs, highly protein?bound (~97%), metabolized by CYP2C9/CYP3A4 to inactive metabolites excreted in urine/feces.


Safety Profile & Handling

Common adverse effects (clinical/preclinical context):

  • GI: bleeding, ulceration, perforation

  • Cardiovascular: increased risk of MI and stroke

  • Others: headache, dizziness, hypertension, renal and hepatic effects

Lab handling recommendations:

  • Use personal protective equipment and follow standard handling for NSAIDs.

  • Monitor study models for GI, cardiovascular, renal, and hepatic markers.

  • Use lowest effective dose for shortest duration.

  • Dispose of unused material as chemical waste.


?? Research?Use Disclaimer

This product is intended solely for laboratory research, and is not approved for therapeutic, diagnostic, clinical, or veterinary applications. Misuse may pose safety risks and compromise data integrity.

Additional information

Weight1.1 kg
Dimensions16 × 18 × 16 cm

Reviews

There are no reviews yet.

Be the first to review “Celecoxib Capsules 1.2g – Grade COX?2 Inhibitor”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare